EssilorLuxottica Société anonyme (ESLOF)
OTCMKTS · Delayed Price · Currency is USD
318.44
-7.31 (-2.24%)
Oct 9, 2025, 3:54 PM EDT
ESLOF Market Cap
ESLOF has a market cap or net worth of $148.24 billion as of October 9, 2025. Its market cap has increased by 39.06% in one year.
Market Cap
148.24B
Enterprise Value
161.94B
Revenue
31.99B
Ranking
n/a
PE Ratio
53.01
Stock Price
$318.44
Market Cap Chart
Since February 11, 1992, ESLOF's market cap has increased from 474.08M to 148.24B, an increase of 31,169.70%. That is a compound annual growth rate of 18.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2025 | 148.24B | 33.35% |
| Dec 31, 2024 | 111.17B | 22.76% |
| Dec 29, 2023 | 90.56B | 14.56% |
| Dec 30, 2022 | 79.05B | -15.86% |
| Dec 31, 2021 | 93.95B | 38.01% |
| Dec 31, 2020 | 68.07B | 3.19% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Elite Pharmaceuticals | 674.12M |
| Glass House Brands | 644.95M |
| Veradigm | 511.83M |
| Northwest Biotherapeutics | 380.49M |
| Nika Pharmaceuticals | 333.67M |
| CytoDyn | 321.63M |
| American Oncology Network | 273.17M |
| Silence Therapeutics | 245.14M |